The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Don't forget the Company and BPOPF have agreed preliminary terms for the Equity Investment portion.
If TLOU and the BPOPF finalise this then Doc Campbell's % would drop considerably.
Could it be that the BPOPF are going to come back asap for their equity share whilst the sp is still so low..?
Any thoughts
Adw, my sentiments exactly mate.
Unfortunately the CEO is incompetent of producing a decent FS even with all the funds reveived over the years.
He'll come away OK tho no fear there.
I'm not sure there was any third parties either tbh, just more bullcack and blarney from Manini.
Like you say it's a lesson learned
I kust had another read of last Novembers RNS and am cringing.
So now instead of putting up $50m in tranches for a 51% stake in BKM, DOID can potentially be owning circa 40% of the entire company including Beutong for whatever price AE sold their "windfall shares" to Gupta plus $8m if they take up the other $5m on offer.
Someone please tell me that's incorrect.
I'm sure they can get a good return.
DOID also have the option of another $5m of shares within the next 12 months which if the SP stayed around todays price would mean they hold a circa 40% stake in the company.
I wonder how long the placement money will last Asiamet, I do hope it's a reasonable amount of time.
GLA